Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of s… https://t.co/kYyOAY6MOf
    about 9 hours ago
  • New post on Science and Enterprise: NIH Funds Programmable mRNA to Treat Cancer https://t.co/DKptaY956d #Science #Business
    about 9 hours ago
  • Attn @ArcticFisheries .. Why Migraine Sufferers May Want to Eat More Fish https://t.co/3AaUvjuNqT
    about 12 hours ago
  • Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and ther… https://t.co/iJUJA00PmY
    about 1 day ago
  • New post on Science and Enterprise: Sanofi Acquires mRNA Developer in $3.2B Deal https://t.co/lRVt9pv3bq #Science #Business
    about 1 day ago

Please share Science & Enterprise

Patent Public Advisory Committee to Meet on 8 July

The Patent Public Advisory Committee to the U.S. Patent and Trademark Office (USPTO) meets on Thursday, 8 July 2010 to review USPTO’s policies and operations related to patents. This session is the group’s fourth of this year.

The patent advisory committee reviews the policies, goals, budget, and user fees set by USPTO, and provides recommendation’s to the agency’s director. The nine-member group chaired by Damon C. Matteo also provides an annual report to the Secretary of Commerce and chairs of the congressional judiciary committees.

The meeting takes place from 8:00 am to 1:30 pm at USPTO’s Madison South Auditorium in Alexandria, Virginia, and is accessible as an online Webcast. The agenda includes a review of USPTO strategy and operations, legislative and judicial updates (including the recent Supreme Court Bilski vs Kappos decision), and reports on process improvement and information technology initiatives.

Updated: 7 July 2010

Comments are closed.